Clinical Trials Logo

Clinical Trial Summary

Purpose:

To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012.

Hypothesis: According to 2012 consensus guidelines, enhanced solid component and main pancreatic duct size of larger than 10 mm will be significant.


Clinical Trial Description

1. Purpose

- To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012

2. Enroll criteria

- Patient who is suspected to have pancreas IPMN on imaging

- Interval between imaging study and surgery is less than 2 months

- Who is scheduled for surgery due to IPMN ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02044926
Study type Observational
Source Asan Medical Center
Contact
Status Terminated
Phase N/A
Start date January 2014
Completion date July 2016

See also
  Status Clinical Trial Phase
Suspended NCT04306939 - Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Not yet recruiting NCT03131076 - Quality of Life Assessment in Patients Who Are Under Surveillance for IPMN N/A
Recruiting NCT04993846 - Pancreatic Cancer and Oral Microbiome
Recruiting NCT04207944 - The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) Phase 2
Active, not recruiting NCT03305146 - Feasibility of Molecular Biology in Pancreatic Cyst Tumors N/A
Completed NCT03914950 - TOF-18F-FDG-PET/CT in Patients With Suspected Pancreatic Cancer N/A
Completed NCT03578445 - Utility of EUS-guided Microbiopsies in Pancreatic Cystic Lesions N/A
Recruiting NCT05117723 - Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer